Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Abzena
Sort By
Newest First
1 / 1
1 / 1
Biopharma
AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L
Abzena
PR-09-24-NI-18
Sep 26, 2024
Investment
Abzena Invests $60m into cGMP Manufacturing Capacity
Abzena
PR-M10-20-06
Oct 13, 2020
ADC
Integrating ADC Manufacturing for the Future
Mark Frigerio, Ph.D.; Juan Carlos Cordova, Ph.D.
Abzena
PAP-Q2-2019-CL-002
May 24, 2019
Appointment
Abzena Announces $20m Investment into Expansion of Integrated Biotherapeutics Offering (Biologics Drug Substance and ADC) and Makes Key Executive Appointment
Abzena
PR-M11-18-NI-036
Nov 06, 2018
Engineering Agreement
Abzena Signs Protein Engineering Agreement with NYU Langone Health
Abzena
PR-M08-18-NI-036
Aug 02, 2018
Bioconjugation
Abzena and Telix sign strategic manufacturing and bioconjugation agreement
Abzena
PR-M07-18-NI-016
Jul 06, 2018
Expanded Capacity
Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site
Marc Technow
Nice Insight
PR-M03-18-NI-105
Mar 30, 2018
Cell Line
Abzena Strengthens Specialized Bioassay Offering Through Access Agreement with Major Cell Line Depository
Abzena
PR-M03-18-NI-053
Mar 15, 2018
Supplier
Abzena Selects Sartorius Stedum Biotech as Supplier of Single-Use Tech
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-033
Jan 19, 2018
Expansion
Abzena Continues to Expand Globally
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-025
Jan 16, 2018
Expanded Capacity
Abzena Takes on New Facilities in Cambridge, UK and San Diego
Abzena
PR-M01-18-NI-013
Jan 08, 2018
Partnership
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol
Abzena
PR-M01-18-NI-011-4917
Jan 04, 2018
Cell Line Development
Abzena and UGA Team Up to Develop MS Therapeutic
Nice Insight
PAO-M10-17-NI-033
Oct 24, 2017
Capacity Expansion
Facility Expansion at Abzena
John Manzello
Abzena
PTV-M06-17-BIO-017
Oct 02, 2017
Oncology
Telix and OBI License Abzena Cancer Fighters
Nice Insight
PAO-M07-17-NI-029
Jul 25, 2017
Biopharmaceutical
Abzena on the Road to BIO: Fueling Biopharmaceutical Development
Sven Lee
Abzena
PTV-M06-17-CL-006
Jun 21, 2017
Biologics
Propagating a Full Spectrum of Services for ADC Development and Manufacture
John Manzello; Campbell Bunce
Abzena
PAP-Q2-17-CL-007
Jun 05, 2017
